命運治療公司
US ˙ NasdaqGM ˙ US31189P1021

SecurityFATE / Fate Therapeutics, Inc.
InstitutionAlliancebernstein L.p.
Latest Disclosed Ownership187,700 shares
Latest Disclosed Value $ 184,434
Alliancebernstein L.p. ownership in FATE / Fate Therapeutics, Inc.

On May 15, 2026 - Alliancebernstein L.p. filed a 13F-HR form disclosing ownership of 187,700 shares of Fate Therapeutics, Inc. (US:FATE) valued at $225,240 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 187,700 shares of Fate Therapeutics, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $371,646 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F FATE THERAPEUTICS COM 31189P102 187,700 0 0.00 184 0.00 0.0001
2026-02-17 2025-12-31 13F FATE THERAPEUTICS COM 31189P102 187,700 0 0.00 184 -22.03 0.0001
2025-11-14 2025-09-30 13F FATE THERAPEUTICS COM 31189P102 187,700 0 0.00 237 12.38 0.0001
2025-08-14 2025-06-30 13F FATE THERAPEUTICS COM 31189P102 187,700 41,120 28.05 210 82.61 0.0001
2025-05-15 2025-03-31 13F FATE THERAPEUTICS COM 31189P102 146,580 0 0.00 116 -52.28 0.0000
2025-02-12 2024-12-31 13F FATE THERAPEUTICS COM 31189P102 146,580 0 0.00 242 -53.02 0.0001
2024-11-14 2024-09-30 13F FATE THERAPEUTICS COM 31189P102 146,580 0 0.00 513 6.88 0.0002
2024-08-14 2024-06-30 13F FATE THERAPEUTICS COM 31189P102 146,580 46,200 46.03 481 -34.78 0.0002
2024-05-14 2024-03-31 13F FATE THERAPEUTICS COM 31189P102 100,380 -60,380 -37.56 737 22.46 0.0003
2024-02-14 2023-12-31 13F FATE THERAPEUTICS COM 31189P102 160,760 -800 -0.50 601 75.73 0.0002
2023-11-14 2023-09-30 13F FATE THERAPEUTICS COM 31189P102 161,560 34,430 27.08 343 -43.47 0.0001
2023-08-15 2023-06-30 13F FATE THERAPEUTICS COM 31189P102 127,130 25,330 24.88 605 4.31 0.0002
2023-05-15 2023-03-31 13F FATE THERAPEUTICS COM 31189P102 101,800 -200,000 -66.27 580 -80.95 0.0002
2023-02-15 2022-12-31 13F FATE THERAPEUTICS COM 31189P102 301,800 200,000 196.46 3,045 33.49 0.0014
2022-11-15 2022-09-30 13F FATE THERAPEUTICS COM 31189P102 101,800 -39,990 -28.20 2,281 -35.09 0.0011
2022-08-15 2022-06-30 13F FATE THERAPEUTICS COM 31189P102 141,790 -157 -0.11 3,514 -36.14 0.0016
2022-05-13 2022-03-31 13F FATE THERAPEUTICS COM 31189P102 141,947 357 0.25 5,503 -33.57 0.0021
2022-02-14 2021-12-31 13F FATE THERAPEUTICS COM 31189P102 141,590 0 0.00 8,284 -1.29 0.0029
2021-11-10 2021-09-30 13F FATE THERAPEUTICS COM 31189P102 141,590 -600 -0.42 8,392 -32.00 0.0033
2021-07-30 2021-06-30 13F FATE THERAPEUTICS COM 31189P102 142,190 13,020 10.08 12,341 15.88 0.0050
2021-05-06 2021-03-31 13F FATE THERAPEUTICS COM 31189P102 129,170 29,970 30.21 10,650 18.07 0.0047
2021-02-08 2020-12-31 13F FATE THERAPEUTICS COM 31189P102 99,200 7,800 8.53 9,020 146.92 0.0043
2020-11-12 2020-09-30 13F FATE THERAPEUTICS COM 31189P102 91,400 5,600 6.53 3,653 24.08 0.0020
2020-08-13 2020-06-30 13F FATE THERAPEUTICS COM 31189P102 85,800 5,100 6.32 2,944 64.29 0.0017
2020-05-14 2020-03-31 13F FATE THERAPEUTICS COM 31189P102 80,700 9,400 13.18 1,792 28.46 0.0013
2020-02-18 2019-12-31 13F FATE THERAPEUTICS COM 31189P102 71,300 2,800 4.09 1,395 31.11 0.0008
2019-11-14 2019-09-30 13F FATE THERAPEUTICS COM 31189P102 68,500 0 0.00 1,064 -23.51 0.0007
2019-08-14 2019-06-30 13F FATE THERAPEUTICS COM 31189P102 68,500 8,700 14.55 1,391 32.35 0.0009
2019-05-14 2019-03-31 13F FATE THERAPEUTICS COM 31189P102 59,800 2,100 3.64 1,051 42.03 0.0007
2019-02-13 2018-12-31 13F FATE THERAPEUTICS COM 31189P102 57,700 15,100 35.45 740 6.63 0.0005
2018-11-08 2018-09-30 13F FATE THERAPEUTICS COM 31189P102 42,600 15,000 54.35 694 121.73 0.0005
2018-08-13 2018-06-30 13F FATE THERAPEUTICS COM 31189P102 27,600 16,600 150.91 313 192.52 0.0002
2018-05-14 2018-03-31 13F FATE THERAPEUTICS COM 31189P102 11,000 11,000 107 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.